The present study demonstrates that combined IFN-γ and PFD treatment has possibly synergistic antifibrotic effects on NHLFs and IPF fibroblasts. Combination therapy with IFN-γ and PFD may be a new and promising approach to the treatment of IPF and should be further explored in clinical trials. This evidence concerns the gene IFNG and idiopathic pulmonary fibrosis.